Asthika Goonewardene Stock Analyst Profile - Truist Securities Research Coverage - Stocknear

Asthika Goonewardene

Stock Analyst at Truist Securities

(2.97)
# 2984
Out of 5,470 analysts
119
Total ratings
Success rate
Average return
29 Stocks
Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Initiates Coverage On: Buy
99
41.06 141.11% 1 Sep 5, 2025
MRSN Mersana Therapeutics
Maintains: Buy
250 36
7.04 411.36% 5 Aug 14, 2025
GILD Gilead Sciences
Upgrades: Buy
108 127
115.88 9.6% 2 Aug 8, 2025
EXEL Exelixis
Maintains: Buy
56 49
37.69 30.01% 11 Jul 29, 2025
GMAB Genmab
Maintains: Strong Buy
45 46
27.54 67.03% 15 Jul 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.27 -21.26% 9 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
151 155
102.66 50.98% 3 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
88 71
34.62 105.08% 2 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 10
1.14 777.19% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 10
1.43 599.3% 4 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 15
2.38 530.25% 6 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 7
4.47 56.6% 3 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
19.45 79.95% 1 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
87 136
71.11 91.25% 5 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 15
0.98 1430.61% 6 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 44
11.44 284.62% 1 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
69 88
67.19 30.97% 2 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 4
1.45 175.86% 5 May 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 19
1.81 949.72% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
229
228.74 0.11% 4 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
n/a n/a 4 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
27
0.76 3452.63% 2 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
15 18
31.23 -42.36% 2 Jun 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Hold
120
25.77 365.66% 1 Apr 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
8 3
1.48 102.7% 3 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
20
23.01 -13.08% 3 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
100 60
2.11 2743.6% 3 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
228 180
4.91 3565.99% 4 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 96
n/a n/a 2 Mar 3, 2020